Kaplan-Meier survival curve analysis revealed that high expression of HMGCS2, IGF2BP1, and METTL16 was significantly correlated with poor prognosis in patients with CRC (Fig. 8D). The gene discussed is IGF2BP1; the disease is colorectal carcinoma.